查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953907

非侵入性人工呼吸器市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、應用、最終用戶、地區和競爭格局分類），2021-2031年

Non-Invasive Ventilators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球非侵入性通氣市場預計將從 2025 年的 32.7 億美元成長到 2031 年的 45.1 億美元，複合年成長率為 5.51%。

這些專用醫療設備可透過鼻罩或面罩進行通氣，並提供正壓通氣，有效避免了侵入性氣管插管。市場成長趨勢主要受慢性呼吸系統疾病（如慢性阻塞性肺病(COPD)）在全球日益普遍以及老齡化人口不斷增加導致呼吸衰竭的驅動。此外，旨在降低醫院再入院率和營運成本的居家照護模式策略轉型也顯著增加了對這些非侵入性治療方案的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 32.7億美元
市場規模：2031年 45.1億美元
複合年成長率：2026-2031年 5.51%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

儘管存在這些成長要素，但由於操作這些精密設備所需的熟練醫護人員嚴重短缺，市場仍面臨巨大的阻力。美國呼吸照護協會的數據顯示，到2024年，87%的呼吸照護主管將意識到呼吸治療師的短缺問題。這種人才短缺嚴重限制了患者獲得關鍵的非侵入性通氣治療的機會，並阻礙了市場在急診和居家醫療領域的更廣泛擴張。

市場促進因素

空氣品質惡化加劇了慢性呼吸系統疾病的快速成長，這是推動非侵入性通氣系統普及應用的主要因素。隨著都市化的不斷推進，長期暴露於粒狀物會加速慢性阻塞性肺病（COPD）的發展，導致患者需要持續可靠的呼吸支持。這種環境影響顯著擴大了需要治療性介入的患者群體。根據美國肺臟協會於2024年4月發布的《2024年空氣污染狀況》報告，美國約有1.312億人居住在臭氧或顆粒物污染程度超標的地區。這項數據與呼吸系統疾病盛行率的上升直接相關，促使醫療保健機構優先考慮採用非侵入性治療方法以實現有效管理。

同時，面向居家照護的技術創新正在改變競爭格局。製造商正在開發支援遠端患者監護的緊湊型雲端設備，從而減少患者頻繁就醫的需求。強勁的財務業績支撐了這一轉變。 Fisher & Paykel Healthcare 於 2024 年 5 月發布的 2024 年年度報告顯示，其居家醫療產品系列的營業收入成長了 18%，顯示醫院以外的人工呼吸器解決方案需求旺盛。這些創新正在推動整體市場收入的成長。 ResMed 於 2024 年 8 月發布的 2024 年第四季業績報告顯示，季度營收成長 9% 至 12.2 億美元，凸顯了該產業的蓬勃發展。

市場挑戰

熟練醫護人員的嚴重短缺是全球無創通氣市場成長的一大障礙。儘管對這類設備的需求不斷成長，但無創正壓通氣的成功實施很大程度上依賴於呼吸治療師的臨床技能，以應對諸如面罩漏氣、壓力調節和患者同步等問題。缺乏訓練有素的人員會導致治療效果降低和失敗率升高，迫使醫療機構削減對新設備的投資。因此，硬體市場面臨的限制因素並非源自於病患需求不足，而是源自於能夠安全有效地操作該技術的專業人員短缺。

由於缺乏能夠在醫院外監測患者的臨床醫生，人才短缺尤其阻礙了居家醫療的策略轉型。不斷成長的患者群體與現有醫護人員之間的差距持續擴大，限制了這些治療方法的擴充性。根據美國國家呼吸治療委員會統計，到2024年，僅有13065名新認證的醫護人員，遠低於填補退休人員空缺和應對日益嚴重的呼吸系統疾病負擔所需的招聘人數。

市場趨勢

人工智慧 (AI) 整合到自適應壓力傳輸領域正在變革這一領域，它使設備能夠根據患者的呼吸模式即時自主調節氣流。這些先進的演算法增強了患者與人工呼吸器的同步性，改善了複雜呼吸系統疾病的治療效果，有效地將技術從簡單的監測發展到主動、自動化的治療最佳化。這種發展減輕了臨床醫生的手動負擔，同時確保了與當前生理需求相符的精準呼吸支持。這些智慧解決方案的廣泛應用顯著提升了製造商的財務表現。例如，瑞思邁 (ResMed) 截至 2025 年 8 月的 10-K 年度報告顯示，其睡眠和呼吸健康業務部門的收入淨額成長了 10%，達到 45 億美元，這主要得益於其數位健康和​​自適應治療平台在全球範圍內的廣泛應用。

同時，市場在新生兒專用非侵入性介面方面取得了顯著進展，這些介面旨在降低早產兒侵入性插管的風險。符合人體工學的鼻罩和專用導管等創新產品在最大限度減少皮膚破損和預防肺支氣管發育不良等長期併發症發揮著關鍵作用，從而促進了新生兒加護病房更早地採用非侵入性支持。使用專用設備保護這些脆弱的兒童患者，推動了對先進重症監護解決方案的強勁需求。反映此一趨勢的是，德爾格公司於2025年3月發布的2024年度報告顯示，其稅前淨利（EBIT）成長16.6%，達到1.94億歐元。該公司將這項財務表現歸功於對其全面的醫療技術產品組合，特別是其尖端新生兒通氣技術的持續需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球非侵入性人工呼吸器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（非侵入性正壓通氣{PPV}，非侵入性負壓通氣{NPV}）
    • 依應用領域（慢性阻塞性肺病和氣喘、呼吸窘迫症候群等）
    • 按最終使用者（醫院/診所、門診護理中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美非侵入性人工呼吸器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲非侵入性人工呼吸器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區非侵入性人工呼吸器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲非侵入性人工呼吸器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲非侵入性人工呼吸器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球非侵入性人工呼吸器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • ResMed Inc.
  • Teleflex Incorporated
  • Hamilton Bonaduz AG
  • Heyer medical AG
  • Koninklijke Philips NV
  • Airon Corporation
  • Fisher & Paykel Healthcare Limited
  • Mindray Medical International Limited
  • Phoenix Medical Systems Pvt. Ltd.
  • Smiths Group plc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23907

The Global Non-Invasive Ventilators Market is projected to expand from a valuation of USD 3.27 Billion in 2025 to USD 4.51 Billion by 2031, reflecting a Compound Annual Growth Rate of 5.51%. These specialized medical devices facilitate ventilation through nasal interfaces or masks, delivering positive airway pressure and effectively bypassing the need for invasive endotracheal intubation. The market's upward trajectory is largely fueled by the increasing global prevalence of chronic respiratory ailments, such as Chronic Obstructive Pulmonary Disease, alongside an aging demographic that is more prone to respiratory failure. Additionally, the strategic pivot toward home-based care models, intended to reduce hospital readmission rates and lower operational expenses, is creating significant demand for these non-invasive therapeutic solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.27 Billion
Market Size 2031USD 4.51 Billion
CAGR 2026-20315.51%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Despite these positive growth factors, the market encounters substantial headwinds due to a critical shortage of skilled healthcare practitioners necessary for managing these sophisticated devices. Data from the American Association for Respiratory Care indicates that in 2024, 87% of respiratory care executives identified a current deficit of respiratory therapists. This workforce scarcity severely restricts patient access to vital non-invasive ventilation therapies and hampers the broader scalability of the market across both acute and home care environments.

Market Driver

The surging prevalence of chronic respiratory conditions, exacerbated by deteriorating air quality, acts as a primary engine for the adoption of non-invasive ventilation systems. As urbanization increases, prolonged exposure to particulate matter hastens the development of Chronic Obstructive Pulmonary Disease, necessitating consistent and reliable respiratory support. This environmental impact significantly widens the patient demographic requiring therapeutic intervention. According to the American Lung Association's 'State of the Air 2024' report published in April 2024, approximately 131.2 million people in the United States reside in areas plagued by unhealthy ozone or particle pollution levels, a statistic that directly correlates with rising respiratory morbidity and drives healthcare providers to prioritize non-invasive modalities for efficient management.

Simultaneously, technological advancements targeted at home-based care are transforming the competitive landscape. Manufacturers are engineering compact, cloud-enabled devices that support remote patient monitoring, thereby decreasing the necessity for frequent hospital visits. This transition is substantiated by robust financial results; Fisher & Paykel Healthcare's 'Annual Report 2024' from May 2024 notes an 18% increase in operating revenue for their Homecare product group, signaling a strong appetite for out-of-hospital ventilation solutions. Such innovations are bolstering overall market revenue, as evidenced by ResMed's 'Fourth Quarter Fiscal Year 2024 Results' in August 2024, which reported a 9% growth in quarterly revenue to $1.22 billion, highlighting the sector's vigorous expansion.

Market Challenge

The critical shortage of skilled healthcare professionals presents a formidable obstacle to the growth of the Global Non-Invasive Ventilators Market. Although demand for these devices is increasing, the successful implementation of non-invasive positive pressure ventilation depends heavily on the clinical proficiency of respiratory therapists to manage issues such as mask leaks, pressure titration, and patient synchrony. A deficiency in trained personnel leads to suboptimal therapy delivery and higher failure rates, compelling healthcare providers to restrict their investments in new equipment. Consequently, the hardware market faces constraints not due to a lack of patient demand, but rather the unavailability of a specialized workforce capable of operating the technology safely and effectively.

This workforce shortage specifically compromises the strategic transition toward home-based care, as there are insufficient clinicians available to monitor patients outside of hospital settings. The disparity between the expanding patient population and the available workforce continues to widen, limiting the potential scalability of these therapies. According to the National Board for Respiratory Care, only 13,065 new credentials were awarded to practitioners in 2024, a number that fails to meet the recruitment levels required to replace retiring staff and address the escalating prevalence of respiratory pathologies.

Market Trends

The integration of Artificial Intelligence for Adaptive Pressure Delivery is transforming the sector by empowering devices to autonomously modulate airflow in response to real-time patient breathing patterns. These sophisticated algorithms enhance patient-ventilator synchrony and augment treatment efficacy for complex respiratory conditions, effectively elevating the technology from simple monitoring to active, automated therapy optimization. This evolution alleviates the manual workload on clinicians while ensuring precise respiratory support aligned with immediate physiological requirements. The growing uptake of these intelligent solutions is significantly enhancing manufacturer performance; for instance, ResMed's 'Form 10-K Annual Report' from August 2025 indicates that net revenue for the Sleep and Breathing Health business rose by 10% to $4.5 billion, driven by the global adoption of their digital health and adaptive therapeutic platforms.

In parallel, the market is experiencing notable advancements in neonatal-specific non-invasive interfaces designed to reduce the risks linked to invasive intubation in premature infants. Innovations such as ergonomic nasal masks and specialized prongs play a crucial role in minimizing skin trauma and preventing long-term complications like bronchopulmonary dysplasia, thereby promoting the early utilization of non-invasive support in neonatal intensive care units. This emphasis on safeguarding vulnerable pediatric patients through specialized hardware is fueling strong demand for high-end critical care solutions. Reflecting this trend, Drager's 'Annual Report 2024' from March 2025 reported a 16.6% rise in Earnings Before Interest and Taxes (EBIT) to EUR 194.0 million, a financial achievement attributed to sustained demand for their comprehensive medical technology portfolio, including leading neonatal ventilation technologies.

Key Market Players

  • ResMed Inc.
  • Teleflex Incorporated
  • Hamilton Bonaduz AG
  • Heyer medical AG
  • Koninklijke Philips N.V.
  • Airon Corporation
  • Fisher & Paykel Healthcare Limited
  • Mindray Medical International Limited
  • Phoenix Medical Systems Pvt. Ltd.
  • Smiths Group plc

Report Scope

In this report, the Global Non-Invasive Ventilators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-Invasive Ventilators Market, By Product

  • Non-invasive Positive Pressure Ventilators {PPV}
  • Non-invasive Negative Pressure Ventilators {NPV}

Non-Invasive Ventilators Market, By Application

  • COPD and Asthma
  • Respiratory Distress Syndrome
  • Others

Non-Invasive Ventilators Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Non-Invasive Ventilators Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-Invasive Ventilators Market.

Available Customizations:

Global Non-Invasive Ventilators Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-Invasive Ventilators Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Non-invasive Positive Pressure Ventilators {PPV}, Non-invasive Negative Pressure Ventilators {NPV})
    • 5.2.2. By Application (COPD and Asthma, Respiratory Distress Syndrome, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Non-Invasive Ventilators Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Non-Invasive Ventilators Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Non-Invasive Ventilators Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Non-Invasive Ventilators Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Non-Invasive Ventilators Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Non-Invasive Ventilators Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Non-Invasive Ventilators Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Non-Invasive Ventilators Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Non-Invasive Ventilators Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Non-Invasive Ventilators Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Non-Invasive Ventilators Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Non-Invasive Ventilators Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Non-Invasive Ventilators Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Non-Invasive Ventilators Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Non-Invasive Ventilators Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Non-Invasive Ventilators Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Non-Invasive Ventilators Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Non-Invasive Ventilators Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Non-Invasive Ventilators Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Non-Invasive Ventilators Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Non-Invasive Ventilators Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Non-Invasive Ventilators Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Non-Invasive Ventilators Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Non-Invasive Ventilators Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Non-Invasive Ventilators Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ResMed Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Teleflex Incorporated
  • 15.3. Hamilton Bonaduz AG
  • 15.4. Heyer medical AG
  • 15.5. Koninklijke Philips N.V.
  • 15.6. Airon Corporation
  • 15.7. Fisher & Paykel Healthcare Limited
  • 15.8. Mindray Medical International Limited
  • 15.9. Phoenix Medical Systems Pvt. Ltd.
  • 15.10. Smiths Group plc

16. Strategic Recommendations

17. About Us & Disclaimer